U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering announces the availability of funding for implementation of the Validation and Advanced Development of Technologies for the Study of Biological Properties of Single Cells (R33) Grant. The purpose of this grant is to accelerate the evaluation of emerging technologies or methodologies for single cell analysis where proof-of-principle has been established and preliminary data are available. Proposed projects should fulfill critical unmet needs in biomedical research and offer compelling advantages to end-users. If successfully optimized and validated, these technologies . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | December 19, 2013

Federal Government Announces Validation and Advanced Development of Technologies for the Study of Biological Properties of Single Cells (R33) Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member